Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.

Medicine (Baltimore) · 2015 · PMC5291600 · PMID 26717359

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

marginal significanceP = 0.066so close (0.05 < p ≤ 0.1)

Disease-specific survival in pCR group was shown to be superior to that of non-pCR group with marginal significance (mean, 56.3 months vs. 41.9 months, P = 0.066), Figure 2 B.

also in 3,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.